{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:09:07Z","timestamp":1792084147575,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371260"],"award-info":[{"award-number":["81371260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313850"],"award-info":[{"award-number":["2017A030313850"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Clinical Department, National Key Discipline, Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases","award":["2014B030301035"],"award-info":[{"award-number":["2014B030301035"]}]},{"name":"Guangzhou Clinical Research and Translational Center for Major Neurological Diseases","award":["201604020010"],"award-info":[{"award-number":["201604020010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10072-019-04123-8","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T01:03:03Z","timestamp":1574125383000},"page":"645-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-term treatment of blepharospasm with botulinum toxin A: a service-based study over a 16-year follow-up in southern China"],"prefix":"10.1007","volume":"41","author":[{"given":"Xiao-bo","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-shu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-biao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-gang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-lin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2547-0960","authenticated-orcid":false,"given":"Wei-xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"4123_CR1","volume-title":"Nervous diseases and their diagnosis : a treatise upon the phenomena produced by diseases of the nervous system, with especial reference to the recognition of their causes","author":"HC Wood","year":"1937","unstructured":"Wood HC (1937) Nervous diseases and their diagnosis : a treatise upon the phenomena produced by diseases of the nervous system, with especial reference to the recognition of their causes. JB Lippincott, Philadelphia"},{"key":"4123_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/jnnp.39.12.1204","volume":"39","author":"CD Marsden","year":"1976","unstructured":"Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghel\u2019s syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry 39:1204\u20131209","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4123_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mds.1275","volume":"17","author":"G Defazio","year":"2002","unstructured":"Defazio G, Livrea P (2002) Epidemiology of primary blepharospasm. Mov Disord 17:7\u201312","journal-title":"Mov Disord"},{"key":"4123_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TD Steeves","year":"2012","unstructured":"Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T (2012) The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 27:1789\u20131796","journal-title":"Mov Disord"},{"key":"4123_CR5","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1212\/WNL.56.11.1579","volume":"56","author":"G Defazio","year":"2001","unstructured":"Defazio G, Livrea P, De Salvia R, Manobianca G, Coviello V, Anaclerio D et al (2001) Prevalence of primary blepharospasm in a community of Puglia region, Southern Italy. Neurology 56:1579\u20131581","journal-title":"Neurology"},{"key":"4123_CR6","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","volume":"86","author":"DM Simpson","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS et al (2016) Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 86:1818","journal-title":"Neurology"},{"key":"4123_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1468-1331.2010.03042.x","volume":"18","author":"A Albanese","year":"2011","unstructured":"Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, Filippini G, Gasser T, Krauss JK, Nardocci N, Newton A, Valls-Sol\u00e9 J (2011) EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 18:5\u201318","journal-title":"Eur J Neurol"},{"key":"4123_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10072-017-2884-y","volume":"38","author":"C Lovati","year":"2017","unstructured":"Lovati C, Giani L (2017) Action mechanisms of Onabotulinum toxin-A: hints for selection of eligible patients. Neurol Sci 38:131\u2013140","journal-title":"Neurol Sci"},{"key":"4123_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/1756285614557475","volume":"8","author":"A Hellman","year":"2015","unstructured":"Hellman A, Torresrussotto D (2015) Botulinum toxin in the management of blepharospasm: current evidence and recent developments. Ther Adv Neurol Disord 8:82","journal-title":"Ther Adv Neurol Disord"},{"key":"4123_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/PRA.0000000000000277","volume":"24","author":"S Chugh","year":"2018","unstructured":"Chugh S, Chhabria A, Jung S, Kruger THC, Wollmer MA (2018) Botulinum toxin as a treatment for depression in a real-world setting. J Psychiatr Pract 24:15\u201320","journal-title":"J Psychiatr Pract"},{"key":"4123_CR11","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2147\/NDT.S141066","volume":"13","author":"B Janis Rebecca","year":"2017","unstructured":"Janis Rebecca B, Sied K, Joan Philipp M, Bettina W, Sebastian P (2017) Depression in blepharospasm: a question of facial feedback? Neuropsychiatr Dis Treat 13:1861\u20131865","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4123_CR12","first-page":"S48","volume":"95","author":"S Kongsengdao","year":"2012","unstructured":"Kongsengdao S, Kritalukkul S (2012) Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. J Med Assoc Thail 95:S48\u2013S54","journal-title":"J Med Assoc Thail"},{"key":"4123_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.parkreldis.2007.03.006","volume":"13","author":"S Ochudlo","year":"2007","unstructured":"Ochudlo S, Bryniarski P, Opala G (2007) Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. Parkinsonism Relat Disord 13:505\u2013508","journal-title":"Parkinsonism Relat Disord"},{"key":"4123_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/mds.26934","volume":"32","author":"G Defazio","year":"2017","unstructured":"Defazio G, Hallett M, Jinnah HA, Conte A, Berardelli A (2017) Blepharospasm 40 years later. Mov Disord 32:498\u2013509","journal-title":"Mov Disord"},{"key":"4123_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ceo.12165","volume":"42","author":"OH Ababneh","year":"2014","unstructured":"Ababneh OH, Cetinkaya A, Kulwin DR (2014) Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Clin Exp Ophthalmol 42:254\u2013261","journal-title":"Clin Exp Ophthalmol"},{"key":"4123_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13760-014-0285-z","volume":"114","author":"H Streitov\u00e1","year":"2014","unstructured":"Streitov\u00e1 H, Bare\u0161 M (2014) Long-term therapy of benign essential blepharospasm and facial hemispasm with botulinum toxin A: retrospective assessment of the clinical and quality of life impact in patients treated for more than 15 years. Acta Neurol Belg 114:285\u2013291","journal-title":"Acta Neurol Belg"},{"key":"4123_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/mds.22368","volume":"24","author":"J Jankovic","year":"2010","unstructured":"Jankovic J, Kenney C, Grafe S, Goertelmeyer R, Comes G (2010) Relationship between various clinical outcome assessments in patients with blepharospasm. Mov Disord 24:407\u2013413","journal-title":"Mov Disord"},{"key":"4123_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/01.IOP.0000065203.88182.CF","volume":"19","author":"EA Bradley","year":"2003","unstructured":"Bradley EA, Hodge DO, Bartley GB (2003) Benign essential blepharospasm among residents of Olmsted County, Minnesota, 1976 to 1995: an epidemiologic study. Ophthalmic Plast Rec 19:177\u2013181","journal-title":"Ophthalmic Plast Rec"},{"key":"4123_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/1756285614557475","volume":"8","author":"A Hellman","year":"2015","unstructured":"Hellman A, Torres-Russotto D (2015) Botulinum toxin in the management of blepharospasm: current evidence and recent developments. Ther Adv Neurol Disord 8:82\u201391","journal-title":"Ther Adv Neurol Disord"},{"key":"4123_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.0b013e3182299e13","volume":"77","author":"G Defazio","year":"2011","unstructured":"Defazio G, Abbruzzese G, Aniello MS, Bloise M, Crisci C, Eleopra R, Fabbrini G, Girlanda P, Liguori R, Macerollo A, Marinelli L, Martino D, Morgante F, Santoro L, Tinazzi M, Berardelli A (2011) Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. Neurology. 77:631\u2013637","journal-title":"Neurology."},{"key":"4123_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/mdc3.12499","volume":"4","author":"A Conte","year":"2017","unstructured":"Conte A, Ferrazzano G, Defazio G, Fabbrini G, Hallett M, Berardelli A (2017) Increased blinking may be a precursor of blepharospasm: a longitudinal study. Mov Disord Clin Pract 4:733\u2013736","journal-title":"Mov Disord Clin Pract"},{"key":"4123_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000381707","volume":"73","author":"XF Huang","year":"2015","unstructured":"Huang XF, Wang KY, Liang ZH, Du RR, Zhou LN (2015) Clinical analysis of patients with primary blepharospasm: a report of 100 cases in China. Eur Neurol 73:337\u2013341","journal-title":"Eur Neurol"},{"key":"4123_CR23","first-page":"45","volume":"7","author":"J Vallssole","year":"2016","unstructured":"Vallssole J, Defazio G (2016) Blepharospasm: update on epidemiology, clinical aspects, and pathophysiology. Front Neurol 7:45","journal-title":"Front Neurol"},{"key":"4123_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1136\/jnnp.60.2.204","volume":"60","author":"VL Soland","year":"1996","unstructured":"Soland VL, Bhatia KP, Marsden CD (1996) Sex prevalence of focal dystonias. J Neurol Neurosurg Psychiatry 60:204\u2013205","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4123_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/IIO.0000000000000207","volume":"58","author":"CJ Hwang","year":"2018","unstructured":"Hwang CJ, Eftekhari K (2018) Benign essential blepharospasm: what we know and what we don\u2019t. Int Ophthalmol Clin 58:11","journal-title":"Int Ophthalmol Clin"},{"key":"4123_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fncom.2017.00011","volume":"11","author":"DA Peterson","year":"2017","unstructured":"Peterson DA, Sejnowski TJ (2017) A dynamic circuit hypothesis for the pathogenesis of blepharospasm. Front Comput Neurosci 11:11","journal-title":"Front Comput Neurosci"},{"key":"4123_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1468-1331.2010.03161.x","volume":"18","author":"EL Peckham","year":"2011","unstructured":"Peckham EL, Lopez G, Shamim EA, Richardson SP, Sanku S, Malkani R et al (2011) Clinical features of patients with blepharospasm: a report of 240 patients. Eur J Neurol 18:382\u2013386","journal-title":"Eur J Neurol"},{"key":"4123_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1212\/CPJ.0000000000000243","volume":"6","author":"R Govindarajan","year":"2016","unstructured":"Govindarajan R, Shepard KM, Moschonas C, Chen JJ (2016) Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: payment policy perspectives. Neurol Clin Pract 6:281\u2013286","journal-title":"Neurol Clin Pract"},{"key":"4123_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/1756285616682676","volume":"10","author":"D Weiss","year":"2017","unstructured":"Weiss D, Sturm J, Hieber L, Bortlein A, Mayr I, Appy M et al (2017) Health-related quality of life outcomes from botulinum toxin treatment in hemifacial spasm. Ther Adv Neurol Disord 10:211\u2013216","journal-title":"Ther Adv Neurol Disord"},{"key":"4123_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/0004-282x20160191","volume":"75","author":"JPM Batisti","year":"2017","unstructured":"Batisti JPM, Kleinfelder ADF, Galli NB, Moro A, Munhoz RP, Teive HAG (2017) Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated. Arq Neuropsiquiatr 75:87\u201391","journal-title":"Arq Neuropsiquiatr"},{"key":"4123_CR31","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/acn3.586","volume":"5","author":"M Pirazzini","year":"2018","unstructured":"Pirazzini M, Carle S, Barth H, Rossetto O, Montecucco C (2018) Primary resistance of human patients to botulinum neurotoxins A and B. Ann Clin Transl Neurol 5:971\u2013975","journal-title":"Ann Clin Transl Neurol"},{"key":"4123_CR32","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s10072-017-3107-2","volume":"38","author":"P Lolekha","year":"2017","unstructured":"Lolekha P, Choolam A, Kulkantrakorn K (2017) A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques. Neurol Sci 38:2031\u20132036","journal-title":"Neurol Sci"},{"key":"4123_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00702-014-1278-z","volume":"122","author":"K Kollewe","year":"2015","unstructured":"Kollewe K, Mohammadi B, K\u00f6hler S, Pickenbrock H, Dengler R, Dressler D (2015) Blepharospasm: long-term treatment with either Botox \u00ae , Xeomin \u00ae or Dysport \u00ae. J Neural Transm (Vienna) 122:427\u2013431","journal-title":"J Neural Transm (Vienna)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04123-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:27:08Z","timestamp":1605655628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04123-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["4123"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04123-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was approved by the institutional ethics committee of The First Affiliated Hospital, Sun Yat-sen University (2018-162). All the patients\u2019 consents were obtained. This experiment conforms to the ethics.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}